Company: TXG
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001770787-25-000018
Chunk: 62

Company: 10x Genomics, Inc.
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 62
---
 a discussion of valuation assumptions used to determine the grant date fair value of the equity awards granted to our NEOs in fiscal year 2024, see Note 9 of Notes to our Consolidated Financial Statements set forth in our Annual Report on Form 10-K for the year ended December 31, 2024. There can be no assurance that the RSUs or PSUs will vest in full or at all (in which case no value with respect to such options or RSUs or PSUs will be realized by the individual) or that the value upon vesting, as applicable, will approximate the fair value as computed in accordance with FASB ASC Topic 718.

(5) The information presented in this line relates to PSUs with performance conditions based on the company’s compound annual growth rate (CAGR) of the company’s revenue over a two-year performance period from January 1, 2024 to December 31, 2025.

(6) The information presented in this line relates to PSUs with performance conditions based on the total shareholder return (TSR) of the company’s common stock as compared to the TSR of the members of the Russell 3000 Medical Equipment and Services Sector Index over a three-year performance period from January 1, 2024 to December 31, 2026.

#### 10X GENOMICS, INC.552025 PROXY STATEMENT

#### Outstanding Equity Awards as of December 31, 2024
The following table lists the outstanding equity awards held by our NEOs as of December 31, 2024. Mr. McAnear separated from the company effective August 30, 2024 and held no outstanding equity awards as of December 31, 2024.

|               |     |            |            |     |            |     |         |     | Stock option awards(1) |        |     |        |     |               |         |     |                                                                                            |   |     |        |     |      |          |            |     |              |   |     |        |     | Stock awards(2) |         |                                                              |     |           |     |                                                               |           |     |                                                                                              |           |     |                                                                                                              |   |
| Name          |     |            | Grant date |     |            |     |         |     | Numbers of             
 securities             
 underlying             
 unexercised            
 stock                  
 options                
 exercisable            
 (#)(3)                 |        |     |        |     | Numbers